|
|
|
|
|
|
|
|
|
|
Blogger's Note: some stats deleted for ease of reading, see abstract eg. OR,,,
abstract
Objective: Hysterectomy and bilateral salpingo-oophorectomy
(BSO) are associated with changes in endogenous hormone levels, yet the
risk of venous thrombosis (VT) associated with hysterectomy and BSO is
incompletely characterized. This study evaluated the risk of incident VT
among postmenopausal women associated with combined prior
hysterectomy/oophorectomy status and current use of hormone therapy
(HT).
Methods: In a case-control study, we identified incident
VT cases (n = 1,623) among postmenopausal Group Health Cooperative
enrollees without reproductive cancer, defining their "index date" as
their VT diagnosis date (1995-2010). Matched controls had not
experienced a prior VT (n = 4,480). Multiple logistic regression models
estimated adjusted relative risks for VT associated with combinations of
prior hysterectomy/oophorectomy status and HT use at the index date.
Results: Compared with women with an intact uterus who
were not using HT, there was no suggestion of greater VT risk in women
with prior hysterectomy without BSO, whether they were or were not using HT. Women with prior hysterectomy and BSO who
were using HT were not at a greater VT risk, but there was evidence of a 25% greater risk associated with
prior hysterectomy with BSO and no current HT use.
Conclusions: Collectively, these and prior data do not
suggest a substantial impact of hysterectomy, with or without BSO, on
the risk of VT among postmenopausal women.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.